Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (201-210 of 500) with videos related to

Pageof 50
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 25, 2017
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor RescueAmandeep Salhotra, Yuan Shan, Ni-Chun Tsai, et al.
Molecular Therapy. Advances|May 15, 2026
IL-12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancerLupita S Lopez, Ziyou Cui, Yukiko Yamaguchi, et al.
Molecular Cytogenetics|November 17, 2010
Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromesMarilyn L Slovak, David D Smith, Victoria Bedell, et al.
Blood|April 17, 2009
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipientsWendi Zhou, Jeff Longmate, Simon F Lacey, et al.
Frontiers in Immunology|December 5, 2018
Effective Targeting of TAG72<sup>+</sup> Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T CellsJohn P Murad, Anna K Kozlowska, Hee Jun Lee, et al.
The New England Journal of Medicine|April 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host DiseaseKaramjeet S Sandhu, Jessica Cheng, Patrick W Mellors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2017
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of HistologyAmrita Y Krishnan, Joycelynne Palmer, Auayporn P Nademanee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2010
Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulationScott E James, Philip D Greenberg, Michael C Jensen, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
IL12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancerLupita S Lopez, Ziyou Cui, Yukiko Yamaguchi, et al.
Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Pageof 50

Showing results (201-210 of 500) with videos related to

Sort By:
Pageof 50
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 25, 2017
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor RescueAmandeep Salhotra, Yuan Shan, Ni-Chun Tsai, et al.
Molecular Therapy. Advances|May 15, 2026
IL-12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancerLupita S Lopez, Ziyou Cui, Yukiko Yamaguchi, et al.
Molecular Cytogenetics|November 17, 2010
Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromesMarilyn L Slovak, David D Smith, Victoria Bedell, et al.
Blood|April 17, 2009
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipientsWendi Zhou, Jeff Longmate, Simon F Lacey, et al.
Frontiers in Immunology|December 5, 2018
Effective Targeting of TAG72<sup>+</sup> Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T CellsJohn P Murad, Anna K Kozlowska, Hee Jun Lee, et al.
The New England Journal of Medicine|April 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host DiseaseKaramjeet S Sandhu, Jessica Cheng, Patrick W Mellors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2017
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of HistologyAmrita Y Krishnan, Joycelynne Palmer, Auayporn P Nademanee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2010
Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulationScott E James, Philip D Greenberg, Michael C Jensen, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
IL12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancerLupita S Lopez, Ziyou Cui, Yukiko Yamaguchi, et al.
Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Pageof 50